RESUMO
Pharmacogenomics is a rapidly growing field of research into the ways in which genetic variation affects drug response. Its objective is to develop precisely targeted, optimal drug therapy. One area of pharmacogenomics focuses on identifying genetic markers for differences in the way people metabolize drugs; another concentrates on developing genetic tests that predict how specific patients will respond to agents such as statins or cancer therapies. Nurses are now called upon to interpret such information or services in order to provide appropriate patient teaching regarding drug selection.
Assuntos
Tratamento Farmacológico/enfermagem , Farmacogenética , Medicina de Precisão , Sistema Enzimático do Citocromo P-450/genética , Testes Genéticos , Humanos , Polimorfismo de Nucleotídeo Único , Terminologia como Assunto , Estados UnidosRESUMO
To comply with clinical agency agreements, nursing administrators and faculty need to be attentive to the management of immunization requests, especially those that are divergent from CDC or state recommendations. As nursing students usually bear the cost of additional immunizations and testing, immunization requirements may represent a barrier in using all available clinical sites. Medical insurers will often reject payment for immunization tests or vaccines that are identified as unnecessary or inconsistent with state or national recommendations. The creation of a consistent immunization process that addresses all guidelines is recommended.
Assuntos
Pessoal de Saúde , Esquemas de Imunização , Estudantes de Enfermagem , Humanos , VacinasRESUMO
The Boston Collaborative Learning Group (BCLG), a 20-member consortium of healthcare agencies and academic institutions, originated in 1996 in response to a demand for innovative cost-effective measures. Directors of Staff Development and academicians collaborate and share resources in planning preceptor education programs. Over 750 Boston area nurses have attended 1 of 10 programs offered. This article provides an historical perspective on forming a consortium and the benefits of this collaborative model.